OAM
Oxford Asset Management Portfolio holdings
AUM
$276M
1-Year Return
17.43%
This Quarter Return
-0.76%
1 Year Return
+17.43%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$209M
AUM Growth
-$14.2M
(-6.4%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-5.95%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
750
New
318
Increased
76
Reduced
53
Closed
298
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$2.27M |
| 2 |
Oracle
ORCL
|
$2.24M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$2M |
| 4 |
Canadian Pacific Kansas City
CP
|
$1.98M |
| 5 |
BlackRock Health Sciences Trust II
BMEZ
|
$1.98M |
Top Sells
| 1 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$3.72M |
| 2 |
Cintas
CTAS
|
$3.13M |
| 3 |
BCOV
Brightcove, Inc.
BCOV
|
$2.87M |
| 4 |
Verizon
VZ
|
$2.3M |
| 5 |
Veeva Systems
VEEV
|
$2.22M |
Sector Composition
| 1 | Healthcare | 15.54% |
| 2 | Financials | 12.73% |
| 3 | Technology | 11.96% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
American Axle
AXL
$706M
| $157K | 0.08% |
38,545
+25,450
| +194% | +$104K |
|
377
Vestis
VSTS
$601M
| $155K | 0.07% |
15,661
-21,785
| -58% | -$216K |
|
|
HUT
378
Hut 8
HUT
$2.68B
| $155K | 0.07% |
13,305
+624
| +5% | +$7.25K |
|
379
EyePoint Pharmaceuticals
EYPT
$966M
| $154K | 0.07% |
+28,357
| New | +$154K |
|
380
Pitney Bowes
PBI
$2.11B
| $153K | 0.07% |
16,944
+6,706
| +66% | +$60.7K |
|
381
MasterBrand
MBC
$1.71B
| $153K | 0.07% |
+11,731
| New | +$153K |
|
|
BBNX
382
Beta Bionics, Inc. Common Stock
BBNX
$878M
| $153K | 0.07% |
+12,500
| New | +$153K |
|
383
BioCryst Pharmaceuticals
BCRX
$1.74B
| $152K | 0.07% |
20,217
+7,052
| +54% | +$52.9K |
|
384
Certara
CERT
$1.69B
| $148K | 0.07% |
+14,951
| New | +$148K |
|
385
Navient
NAVI
$1.37B
| $146K | 0.07% |
+11,523
| New | +$146K |
|
386
Bioventus
BVS
$481M
| $145K | 0.07% |
+15,838
| New | +$145K |
|
387
Prospect Capital
PSEC
$1.34B
| $144K | 0.07% |
35,052
+15,491
| +79% | +$63.5K |
|
388
C4 Therapeutics
CCCC
$194M
| $138K | 0.07% |
+86,224
| New | +$138K |
|
389
Viemed Healthcare
VMD
$267M
| $138K | 0.07% |
18,937
+6,767
| +56% | +$49.3K |
|
390
Rezolute
RZLT
$696M
| $137K | 0.07% |
47,301
+15,890
| +51% | +$46.1K |
|
391
SunCoke Energy
SXC
$667M
| $137K | 0.07% |
+14,870
| New | +$137K |
|
392
PennantPark Floating Rate Capital
PFLT
$1.02B
| $136K | 0.07% |
+12,186
| New | +$136K |
|
393
Kelly Services Class A
KELYA
$489M
| $135K | 0.06% |
10,264
-7,435
| -42% | -$97.9K |
|
394
Semrush
SEMR
$1.15B
| $134K | 0.06% |
+14,339
| New | +$134K |
|
395
Future Fuel
FF
$173M
| $132K | 0.06% |
+33,769
| New | +$132K |
|
396
Clover Health Investments
CLOV
$1.41B
| $131K | 0.06% |
+36,515
| New | +$131K |
|
397
Vir Biotechnology
VIR
$732M
| $127K | 0.06% |
+19,626
| New | +$127K |
|
398
Taboola.com
TBLA
$1,000M
| $121K | 0.06% |
+41,093
| New | +$121K |
|
399
Northfield Bancorp
NFBK
$498M
| $121K | 0.06% |
+11,089
| New | +$121K |
|
|
SRTA
400
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$332M
| $120K | 0.06% |
+43,868
| New | +$120K |
|